# Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

> **NCT05674994** · PHASE3 · RECRUITING · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 110 (estimated)

## Conditions studied

- Acute Exacerbation of Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Methylprednisone/Prednisone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05674994
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-26
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05674994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05674994, "Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05674994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*